Company intelligence / Profile preview
Immunomic Therapeutics, Inc.
Rockville, Maryland, United Statesimmunomix.com ↗
- Ownership
- Private
- Development stage
- Phase 2
01
Overview
Immunomic Therapeutics is developing immunotherapeutics with a focus on treating and preventing various oncology indications. Their LAMP-Vax platform is being investigated for use in cancer, allergies, and animal health applications.
- Therapeutic areas
- OncologyImmunology
- Modalities
- Nucleic acid immunotherapyvaccines
- Industry
- Biotech
02
Drug pipeline
18 assets17 more assets in the full pipeline.
03
Partnerships
Lineage Cell Therapeutics (license agreement announced in April 2021)
Beyond the preview
Go deeper on Immunomic Therapeutics, Inc..
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Immunomic Therapeutics, Inc..